April 13, 2024

Gastroenterology Market Size To Cross USD 93.8 Bn By 2032

The global gastroenterology market size accounted for US$ 51.37 Bn in 2022 and is projected to reach around USD 93.8 Bn by 2032, growing at a CAGR of 6.21% from 2023 to 2032.

Gastroenterology Market Size 2023 To 2032

Report Summary

The global gastroenterology market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the gastroenterology market across the globe.

A comprehensive estimate on the gastroenterology market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of gastroenterology during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2618

Gastroenterology Market Report Scope

Report CoverageDetails
Market Size in 2023USD 54.56 Billion
Market Size by 2032USD 93.8 Billion
Growth Rate from 2023 to 2032CAGR of 6.21%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Type, By Distribution Channel, By Application and By Route of Administration

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized gastroenterology market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Artificial Intelligence (AI) in Biotechnology Market Size Analysis 2023 To 2032

Gastroenterology Market Players

The report includes the profiles of key gastroenterology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Abbott Laboratories
  • Johnson & Johnson
  • AbbVie Inc.
  • Salix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • ALLERGAN
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Astellas Pharma US, Inc.
  • Pfizer Inc.

Market Segmentation

By Type

  • Branded
  • Generics

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Application

  • Crohn’s Disease
  • Ulcerative Colitis
  • GERD
  • IBS
  • Others

By Route of Administration

  • Injectable
  • Oral & Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Gastroenterology Market 

5.1. COVID-19 Landscape: Gastroenterology Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Gastroenterology Market, By Type

8.1. Gastroenterology Market, by Type, 2023-2032

8.1.1. Branded

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Generics

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Gastroenterology Market, By Distribution Channel

9.1. Gastroenterology Market, by Distribution Channel, 2023-2032

9.1.1. Retail Pharmacies

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Hospital Pharmacies

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Gastroenterology Market, By Application 

10.1. Gastroenterology Market, by Application, 2023-2032

10.1.1. Crohn’s Disease

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Ulcerative Colitis

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. GERD

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. IBS

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Gastroenterology Market, By Route of Administration 

11.1. Gastroenterology Market, by Route of Administration, 2023-2032

11.1.1. Injectable

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Oral & Others

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Gastroenterology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Route of Administration (2020-2032)

Chapter 13. Company Profiles

13.1. Abbott Laboratories

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Johnson & Johnson

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. AbbVie Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Salix Pharmaceuticals

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GlaxoSmithKline Plc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. ALLERGAN

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Takeda Pharmaceutical Company Limited

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. AstraZeneca

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Astellas Pharma US, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Pfizer Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com